Concepedia

Roland Landman

RL

Statistics

Publications

52

Citations

1.8K

H-Index

25

Active since

1989

Affiliations

Inserm(Current)

Hôpital Bichat-Claude-Bernard

Université Claude Bernard Lyon 1

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Roland Landman is an author at Inserm specializing in antiretroviral therapy, antiviral therapy, and infectious diseases.

Publications per year

1989–2024

52

Publications

52

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Dominique Roulot, Ségolène Brichler, Richard Layese et al. · Journal of Hepatology · 2020 · 154 citations

, , +16

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

José Ramón Arribas, Pierre‐Marie Girard, Roland Landman et al. · The Lancet Infectious Diseases · 2015 · 143 citations · Full text

, , +17

PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA RELAPSE BY PENTAMIDINE AEROSOL IN ZIDOVUDINE-TREATED AIDS PATIENTS

Pierre‐Marie Girard, C. Gaudebout, Philippe Lottin et al. · The Lancet · 1989 · 96 citations

, , +10

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

Roland Landman, Ricarda Schiemann, Safiatou Thiam et al. · AIDS · 2003 · 90 citations

, , +15

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 80 citations

, , +17

1–5 of 52